Simple method to eliminate the risk of inadvertent intrathecal vincristine administration

Journal of Clinical Oncology

Volumn 21, Issue 10, 2003, Pages 2044-

  Stefanou, Angela ^a   Dooley, Michael ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VINCRISTINE;

HUMAN; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEDICATION ERROR; NOTE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SPINAL; MEDICATION ERRORS; VINCRISTINE;

EID: 0038011927     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.99.022     Document Type: Letter

References (4)

1. Shepherd DA, Steuber CP, Starling KA, et al: Accidental intrathecal administration of vincristine. Med Pediatr Oncol 5:85-88, 1978.
2. Alcaraz A, Rey C, Concha A, et al: Intrathecal vincristine: Fatal myeloencephalopathy despite cerebrospinal fluid perfusion. J Toxicol Clin Toxicol 40:557-561, 2002.
3. Dyer C: Doctors suspended after injecting wrong drug into spine. BMJ 322:257-258, 2001.
4. Womer RB, Tracy E, Soo-Hoo W, et al: Multidisciplinary systems approach to chemotherapy safety: Rebuilding processes and holding the gains. J Clin Oncol 20:4705-4712, 2002.